Effects of lenalidomide on the bone marrow microenvironment in acute myeloid leukemia: Translational analysis of the HOVON103 AML/SAKK30/10 Swiss trial cohort

This translational study aimed at gaining insight into the effects of lenalidomide in acute myeloid leukemia (AML). Forty-one AML patients aged 66 or older of the Swiss cohort of the HOVON-103 AML/SAKK30/10 study were included. After randomization, they received standard induction chemotherapy with...

Descripción completa

Detalles Bibliográficos
Autores principales: Brune, Magdalena M., Stüssi, Georg, Lundberg, Pontus, Vela, Visar, Heim, Dominik, Manz, Markus G., Haralambieva, Eugenia, Pabst, Thomas, Banz, Yara, Bargetzi, Mario, Grobholz, Rainer, Fehr, Martin, Cogliatti, Sergio, Ossenkoppele, Gert J., Löwenberg, Bob, Rudolf, Christina Biaggi, Li, Qiyu, Passweg, Jakob, Mazzuchelli, Luca, Medinger, Michael, Tzankov, Alexandar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043896/
https://www.ncbi.nlm.nih.gov/pubmed/33704530
http://dx.doi.org/10.1007/s00277-021-04467-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8043896/
https://www.ncbi.nlm.nih.gov/pubmed/33704530
http://dx.doi.org/10.1007/s00277-021-04467-2

Ejemplares similares